Xiangzhong Ye Selected Research

Headache (Headaches)

12/2023

Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiangzhong Ye Research Topics

Disease

4	Infections 07/2022 - 10/2016
3	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 12/2020 - 01/2017
2	COVID-19 12/2023 - 07/2022
2	Herpes Zoster 11/2022 - 08/2012
2	Human Influenza (Influenza) 07/2022 - 01/2017
1	Headache (Headaches) 12/2023
1	Chickenpox 11/2022
1	Neoplasms (Cancer) 01/2022
1	Exanthema (Rash) 10/2016

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 12/2023 - 08/2012
2	AntigensIBA 10/2016 - 08/2012
1	COVID-19 VaccinesIBA 12/2023
1	Proteins (Proteins, Gene)FDA Link 07/2022
1	Single-Chain AntibodiesIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2017
1	AntibodiesIBA 01/2017
1	Nucleic AcidsIBA 01/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	Indicators and Reagents (Reagents)IBA 10/2016
1	Antiviral Agents (Antivirals)IBA 10/2016
1	Therapeutic UsesIBA 10/2016

Therapy/Procedure

1	Immunotherapy 01/2022